Features
Current Status of Excimer Laser Trabeculostomy
Numerous studies indicate that ELT is a safe and effective procedure to significantly lower intraocular pressure and reduce medications.
By Mark J. Gallardo, MD, RICHARD A. LEWIS, M.D.
The Relevance of Retinal Ganglion Cell Function to Glaucoma Treatments
Identifying early stress could prevent damage.
By Kristin Mohr, OD, TANNER J. FERGUSON, MD
Micropulse Laser for Glaucoma in Patients With an Active Lifestyle
Patients can return to activity soon after the procedure.
By Analisa Arosemena, MD
Combining Endoscopic Cyclophotocoagulation With Microinvasive Glaucoma Surgery
Recent data reveal its potential benefits.
By Nariman Nassiri, MD, MPH, Brian A. Francis, MD, MS
Web Exclusives
The Use of Artificial Intelligence Chatbots in Ophthalmology
Artificial intelligence tools could help increase glaucoma drop compliance.
By Saif Aldeen Alryalat, MD, MALIK KAHOOK, M.D.
Uptake of MIGS Among Glaucoma Specialists
Ophthalmologists discuss where minimally invasive procedures fit in their treatment paradigm for glaucoma.
By Susan L. Worley, contributing writer
Departments
From the Editor: Glaucoma Is a Disease of Change
By Conni Koury, contributing editor
Coding: Reimbursement for Treating MIGS Complications
Review the Medicare rules for proper coding.
By Kevin J. Corcoran, COE, CPC, CPMA, FNAO, Brandy H. Sperry, COMT, COE, CPC, CPMA
Product Spotlight: Streamlining the Surgical Process to Lower Intraocular Pressure
Device addresses multiple sights of outflow resistance with the press of a button.
By Karen Appold, contributing writer
News
Thea Pharma Receives FDA Approval for Iyuzeh Preservative-free Latanoprost
By Jennifer Ford, senior managing editor
Ophthalmologists Face 8.5% Cut in Medicare Reimbursement for 2023
CMS final rule, released November 1, reduces physician reimbursement while increasing ASC and hospital fees.
By Jim Gallagher, senior managing editor
FDA Approves Omlonti for IOP Reduction in POAG Patients
By Conni Koury, contributing editor
European Medicines Agency Accepts Santen's Application for Preservative-free Latanoprost Emulsion
By Conni Koury, contributing editor
Early Onset of Diabetes, Hypertension Can Predict Early Glaucoma
By Conni Koury, contributing editor
Role of Alzheimer-linked APOE Gene in Glaucoma Protection Uncovered
By Conni Koury, contributing editor
Glaucoma Patients at Significant Risk of Alzheimer Disease
By Conni Koury, contributing editor
SpyGlass Pharma Presents First-in-human Data on IOL-based Drug-delivery Platform
By Conni Koury, contributing editor
Glaukos Announces FDA 510(k) Clearance of iStent infinite
By Conni Koury, contributing editor
Phase 3 Study of Glaukos iDose TR Met Primary Efficacy Endpoints
By Conni Koury, contributing editor
LiGHT 6-year Results Show SLT Safe for OAG, Superior to Drops
By Conni Koury, contributing editor
Regulators in Europe Approve Pixium's Remote Rehab System for Use in Clinical Trials
By Conni Koury, contributing editor
Sion Bladeless Goniotomy Device Introduced
By Conni Koury, contributing editor
Vitamin Combo May Help Prevent Glaucoma
By Conni Koury, contributing editor
Daily Sepetaprost Noninferior to Twice-daily Timolol for IOP Lowering
By Conni Koury, contributing editor
Patients Value Timeliness, Friendliness, and Modern Technology When Choosing Providers, Practices
By Conni Koury, contributing editor
Omni 3-year Standalone Data Show IOP Efficacy, Reduced Need for Meds in OAG Patients
By Conni Koury, contributing editor
Global Data Registry Launched to Support Canaloplasty for Glaucoma
By Conni Koury, contributing editor